C. S. Fuchs Et Al. , "The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.," JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15, 2020
Fuchs, C. S. Et Al. 2020. The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.. JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15 .
Fuchs, C. S., Ozguroglu, M., Bang, Y., Di Bartolomeo, M., Mandala, M., Ryu, M., ... Vivaldi, C.(2020). The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.. JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15.
Fuchs, Charles Et Al. "The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.," JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15, 2020
Fuchs, Charles S. Et Al. "The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.." JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15, 2020
Fuchs, C. S. Et Al. (2020) . "The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.." JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15.
@article{article, author={Charles S. Fuchs Et Al. }, title={The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2020}